CA Patent

CA2634073C — Compositions comprising ingenol-3-angelate

Assigned to Individual · Expires 2013-11-19 · 12y expired

What this patent protects

The present invention relates to ingenol angelate, and particularly formulations comprising ingenol-3-angelate stabilised by dissolving it in an aprotic solvent (such as benzyl alcohol) in the presence of an acidic buffer.

USPTO Abstract

The present invention relates to ingenol angelate, and particularly formulations comprising ingenol-3-angelate stabilised by dissolving it in an aprotic solvent (such as benzyl alcohol) in the presence of an acidic buffer.

Drugs covered by this patent

Patent Metadata

Patent number
CA2634073C
Jurisdiction
CA
Classification
—
Expires
2013-11-19
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.